Your browser doesn't support javascript.
loading
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.
Kustin, Talia; Harel, Noam; Finkel, Uriah; Perchik, Shay; Harari, Sheri; Tahor, Maayan; Caspi, Itamar; Levy, Rachel; Leshchinsky, Michael; Ken Dror, Shifra; Bergerzon, Galit; Gadban, Hala; Gadban, Faten; Eliassian, Eti; Shimron, Orit; Saleh, Loulou; Ben-Zvi, Haim; Keren Taraday, Elena; Amichay, Doron; Ben-Dor, Anat; Sagas, Dana; Strauss, Merav; Shemer Avni, Yonat; Huppert, Amit; Kepten, Eldad; Balicer, Ran D; Netzer, Doron; Ben-Shachar, Shay; Stern, Adi.
Afiliação
  • Kustin T; The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Harel N; Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel.
  • Finkel U; The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Perchik S; Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel.
  • Harari S; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
  • Tahor M; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
  • Caspi I; The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Levy R; Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel.
  • Leshchinsky M; The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Ken Dror S; The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Bergerzon G; The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Gadban H; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
  • Gadban F; Clalit Health Services, Central Laboratories, Haifa and Western Galilee, Nesher, Israel.
  • Eliassian E; Clalit Health Services, Central Laboratories, Haifa and Western Galilee, Nesher, Israel.
  • Shimron O; Clalit Health Services, Central Laboratories, Haifa and Western Galilee, Nesher, Israel.
  • Saleh L; Clalit Health Services, Central Laboratories, Haifa and Western Galilee, Nesher, Israel.
  • Ben-Zvi H; Progenin Laboratories, Jerusalem District, Clalit Health Services, Tel Aviv, Israel.
  • Keren Taraday E; Progenin Laboratories, Jerusalem District, Clalit Health Services, Tel Aviv, Israel.
  • Amichay D; Microbiology lab, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel.
  • Ben-Dor A; Microbiology lab, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel.
  • Sagas D; Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
  • Strauss M; Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
  • Shemer Avni Y; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel.
  • Huppert A; Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
  • Kepten E; Microbiology Laboratory, Emek Medical Center, Afula, Israel.
  • Balicer RD; Microbiology Laboratory, Emek Medical Center, Afula, Israel.
  • Netzer D; Laboratory of Clinical Virology, Soroka University Medical Center, Beersheba, Israel.
  • Ben-Shachar S; Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel.
  • Stern A; The Bio-statistical and Bio-mathematical Unit, The Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel.
Nat Med ; 27(8): 1379-1384, 2021 08.
Article em En | MEDLINE | ID: mdl-34127854

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article